Left Main Coronary Artery Stenting: Risks, Benefits & Considerations
Percutaneous coronary intervention (PCI) of the left main coronary artery (LMCA) is a high-risk, complex procedure reserved for select patients.
Indications
- Severe LMCA stenosis (>50%) with unstable angina or NSTEMI
- Unsuitable for coronary artery bypass grafting (CABG) due to comorbidities, frailty, or patient preference
- Heart Team consensus (interventional cardiologist + cardiac surgeon)
Key Risks
- Periprocedural MI, stroke, death (higher than non-LMCA PCI)
- Stent thrombosis
- Restenosis (lower with drug-eluting stents)
- Distal embolization
Stent Selection
Drug-eluting stents (DES) are strongly preferred over bare-metal stents (BMS) due to significantly lower restenosis and target lesion revascularization rates. Newer-generation DES (everolimus, zotarolimus) have improved safety profiles.
Procedural Considerations
- Intravascular imaging (IVUS/OCT) mandatory for optimal sizing and apposition
- Provisional T-stenting or culotte technique for bifurcation lesions
- Prolonged dual antiplatelet therapy (DAPT) – typically ≥12 months
Shared decision-making with the Heart Team and patient is essential, weighing LMCA-PCI against CABG and medical therapy.
Cardiovascular Disease - Related Articles
- Understanding Heart Murmurs: A Comprehensive Assessment
- Cardiovascular Health: Comprehensive Prevention and Management
- Lower Your Resting Heart Rate: A Comprehensive Guide
- Cardio Exercise Lowers Resting Heart Rate: Mechanisms and Individual Variation
- Vascular Health Screening: Tests Included and Why They Matter
- Peripheral Artery Disease (PAD): Causes, Symptoms & Treatment
- Understanding Resting Heart Rate for Women Over 65: Normal Range and Target Zones
